Cat. No.: DAB-0012594
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Host Species | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Applications | WB |
| Product Description | Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser561 of human PLD1. Antibodies are purified by protein A and peptide affinity chromatography. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | PLD1 |
| UniProt No. | Q13393 |
| Gene ID | 5337 |
| Gene Description | Phosphatidylcholine-specific phospholipase D hydrolyzes phosphatidylcholine to produce choline and phosphatidic acid. PA is the precursor of the second messenger, diacylglycerol. Two isoforms of PLD have been identified so far. Both are regulated by protein kinases, small GTPases and Ca2+. PLD1 is phosphorylated at Ser2, Ser561, and Thr147 by PKC. Phosphorylation at Thr147 and Ser561 regulates PLD1 activity. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
